ADAMTS13 Improving the Cell Engraftment Efficacy in Mouse Model of Bone Marrow Transplantation

被引：0
|
作者：
Matsui, Hideto [1 ]
Doi, Masaaki [1 ]
Matsunari, Yasunori [1 ]
Takeda, Maiko [1 ]
Nishio, Kenji [1 ]
Shima, Midori [1 ]
Soejima, Kenji [2 ]
Banno, Fumiaki [3 ]
Akiyama, Masashi [3 ]
Kokame, Koichi [3 ]
Miyata, Toshiyuki [3 ]
Sugimoto, Mitsuhiko [1 ]
机构：
[1] Nara Med Univ, Kashihara, Nara 634, Japan
[2] Chemoserotherapeut Res Inst, Res Dept 1, Kumamoto, Japan
[3] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.1077.1077
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1077
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ADAMTS13 accelerates the cell engraftment efficacy in mouse model of bone marrow transplantation
    Matsui, H.
    Doi, M.
    Matsunari, Y.
    Takeda, M.
    Nishio, K.
    Shima, M.
    Soejima, K.
    Banno, F.
    Miyata, T.
    Sugimoto, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 458 - 458
  • [2] Contribution of ADAMTS13 to the better cell engraftment efficacy in mouse model of bone marrow transplantation
    Matsui, Hideto
    Takeda, Maiko
    Soejima, Kenji
    Matsunari, Yasunori
    Kasuda, Shogo
    Ono, Shiro
    Nishio, Kenji
    Shima, Midori
    Banno, Fumiaki
    Miyata, Toshiyuki
    Sugimoto, Mitsuhiko
    HAEMATOLOGICA, 2014, 99 (10) : E211 - E213
  • [3] Efficacy of a recombinant ADAMTS13 in a mouse model of thrombotic thrombocytopenic purpura
    Schiviz, A.
    Resch, M.
    Farnleitner, E.
    Scheiflinger, F.
    Schwarz, H.
    Hoellriegl, W.
    Muchitsch, E.
    HAEMOPHILIA, 2012, 18 : 188 - 188
  • [4] Alterations of plasma VWF and ADAMTS13 activity in the patients receiving bone marrow transplantation
    Han, Y.
    Hu, L.
    Su, J.
    Wang, Q.
    Bai, X.
    Wang, Z.
    Wu, D.
    Ruan, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1052 - 1052
  • [5] Association Between ADAMTS13 Activity and the Prognosis of Multiple Myeloma After Bone Marrow Transplantation
    Rakha, Nahed Moawad
    Abdelwaheed, Essam
    Adel, Nermine
    Sabri, Ahmed
    Fekry, Gehad Hamada
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S533 - S534
  • [6] Preclinical efficacy testing of Baxter's recombinant ADAMTS13 in a mouse model of TTP
    Schiviz, A.
    Lawo, J. P.
    Wuersch, K.
    Ehrlich, H.
    Scheiflinger, F.
    Schwarz, H-P
    Hoellriegl, W.
    Muchitsch, E-M
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 26 - 26
  • [7] Preclinical Efficacy Testing of Baxter's Recombinant ADAMTS13 in a Mouse Model of TTP
    Schiviz, Alexandra
    Resch, Marlene
    Farnleitner, Elisa
    Rottensteiner, Hanspeter
    Scheiflinger, Friedrich
    Schwarz, Hans Peter
    Hoellriegl, Werner
    Muchitsch, Eva-Maria
    BLOOD, 2012, 120 (21)
  • [8] Prophylactic and therapeutic efficacy of a recombinant ADAMTS13 in a mouse model of thrombotic thrombocytopenic purpura
    Schiviz, A.
    Verdino, D.
    Resch, M.
    Farnleitner, E.
    Scheiflinger, F.
    Schwarz, H. P.
    Muchitsch, E. M.
    Hoellriegl, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 457 - 457
  • [9] Improving on nature: redesigning ADAMTS13
    Hovinga, Johanna A. Kremer
    Voorberg, Jan
    BLOOD, 2012, 119 (16) : 3654 - 3655
  • [10] Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation
    Peyvandi, F.
    Siboni, S. M.
    Deliliers, D. Lambertenghi
    Lavoretano, S.
    De Fazio, N.
    Moroni, B.
    Deliliers, G. Lambertenghi
    Mannucci, P. Mannuccio
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (02) : 187 - 195
12345